MorganRosel Wealth Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,143
Closed -$133K 105
2024
Q1
$133K Hold
11,143
0.05% 104
2023
Q4
$120K Hold
11,143
0.05% 97
2023
Q3
$154K Buy
+11,143
New +$163K 0.06% 95
2022
Q4
Sell
-10,245
Closed -$120K 103
2022
Q3
$120K Buy
+10,245
New +$146K 0.06% 89
2022
Q2
Sell
-31,809
Closed -$492K 94
2022
Q1
$492K Sell
31,809
-3,020
-9% -$38.1K 0.24% 67
2021
Q4
$294K Hold
34,829
0.14% 72
2021
Q3
$313K Buy
34,829
+13,609
+64% +$110K 0.17% 74
2021
Q2
$211K Hold
21,220
0.12% 81
2021
Q1
$151K Hold
21,220
0.1% 78
2020
Q4
$112K Buy
+21,220
New +$83.4K 0.08% 73
2020
Q1
Sell
-18,732
Closed -$197K 77
2019
Q4
$197K Hold
18,732
0.15% 73
2019
Q3
$160K Buy
18,732
+1,513
+9% +$14.8K 0.13% 68
2019
Q2
$198K Hold
17,219
0.16% 68
2019
Q1
$241K Sell
17,219
-6,475
-27% -$84.9K 0.2% 63
2018
Q4
$245K Buy
+23,694
New +$349K 0.25% 58

Other funds holding PTEN

MorganRosel Wealth Management's PTEN Position: Q2 2024 in Review

MorganRosel Wealth Management sold out of Patterson-UTI (PTEN) in Q2 2024, closing a stake of 11,143 shares — an estimated $133K sold.

MorganRosel Wealth Management first reported a position in PTEN in Q4 2018 and held it in 15 quarters. The position peaked at $492K in Q1 2022. 359 funds tracked by Wall St. Rank hold PTEN as of Q2 2024.

  • MorganRosel Wealth Management reported no remaining Patterson-UTI position as of Q2 2024 after selling out during the quarter.
  • MorganRosel Wealth Management sold 11,143 Patterson-UTI shares in Q2 2024, an estimated $133K.
  • MorganRosel Wealth Management first reported a position in Patterson-UTI in Q4 2018 and held it in 15 quarters.
  • MorganRosel Wealth Management's Patterson-UTI position peaked at $492K in Q1 2022.
  • 359 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2024.

Based on MorganRosel Wealth Management's 13F filing for Q2 2024, filed 15 Jul 2024.